Brunie Felding

About

Brunie Felding is a biomedical researcher associated with Scripps Research and publicly described as a principal investigator studying breast cancer metastasis and NAD+ metabolism. She serves on the Scientific Advisory Board of Niagen Bioscience (formerly ChromaDex). Public references around ChromaDex's 2017 patent-license agreement indicate her work contributed patented discoveries relevant to NAD+ precursor research.

Areas of interest